Novogen Ltd (NRT) - Financial and Strategic SWOT Analysis Review

November 2017 | 43 pages | ID: N5B636E295DEN
GlobalData

Abstracts

Novogen Ltd (NRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Key manufacturing facilities – A list of key manufacturing facilities of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Novogen Ltd (Novogen) is a clinical stage biotechnology company which focuses on the discovery and development of anti-cancer drugs. It develops its products based on three drug technology platforms, phosphoinositide 3-kinase (PI3K) inhibitors, anti-tropomyosins (ATM) and super-benzopyrans (SBP). ATM drugs that target the cancer cell cytoskeleton are being developed for the treatment of melanoma, prostate cancer and neuroblastoma. SBP drugs that target cancer stem cells are being developed for the treatment of ovarian cancer and glioblastoma. The PI3K inhibitor functions by inhibiting an important signaling pathway which is critical to the development of certain kinds of tumors. The company’s product pipeline includes PI3K GDC-0084; Cantrixil (TRX-E-002-1); Trilexium (TRXE-009-1). Novogen is headquartered in New South Wales, Australia.

Novogen Ltd Key Recent Developments

Aug 29,2017: Novogen Annual Report And Full-year Financial Results
Aug 14,2017: Novogen: Board Review Of Business Operations And Governance
Jun 08,2017: Novogen Streamlines Board and Costs
Mar 10,2017: Novogen Announces Transformation to a Clinical Stage Organisation Leads to Changes in Management Structure
Mar 10,2017: Novogen: Transformation To A Clinical Stage Organisation Leads To Changes In Management Structure

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Novogen Ltd - Key Facts
Novogen Ltd - Key Employees
Novogen Ltd - Key Employee Biographies
Novogen Ltd - Major Products and Services
Novogen Ltd - History
Novogen Ltd - Company Statement
Novogen Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Novogen Ltd - Business Description
Novogen Ltd - Corporate Strategy
Novogen Ltd - SWOT Analysis
SWOT Analysis - Overview
Novogen Ltd - Strengths
Novogen Ltd - Weaknesses
Novogen Ltd - Opportunities
Novogen Ltd - Threats
Novogen Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Novogen Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Novogen Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Novogen Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Aug 29, 2017: Novogen Annual Report And Full-year Financial Results
Aug 14, 2017: Novogen: Board Review Of Business Operations And Governance
Jun 08, 2017: Novogen Streamlines Board and Costs
Mar 10, 2017: Novogen Announces Transformation to a Clinical Stage Organisation Leads to Changes in Management Structure
Mar 10, 2017: Novogen: Transformation To A Clinical Stage Organisation Leads To Changes In Management Structure
Sep 05, 2016: Novogen Appoints Scientific Advisory Board To Guide Development Of Oncology Pipeline
Aug 29, 2016: Novogen Appoints Key Management Personnel To Drive Transition To A Development - Focused Organisation
Feb 05, 2016: Novogen Announces Changes to the Board with New Chairman and Deputy Chairman Appointed

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Novogen Ltd, Key Facts
Novogen Ltd, Key Employees
Novogen Ltd, Key Employee Biographies
Novogen Ltd, Major Products and Services
Novogen Ltd, History
Novogen Ltd, Subsidiaries
Novogen Ltd, Key Competitors
Novogen Ltd, Ratios based on current share price
Novogen Ltd, Annual Ratios
Novogen Ltd, Annual Ratios (Cont.1)
Novogen Ltd, Interim Ratios
Novogen Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Novogen Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Novogen Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Novogen Ltd, Performance Chart (2013 - 2017)
Novogen Ltd, Ratio Charts
Novogen Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Novogen Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Viralytics Ltd
Teva Pharmaceutical Industries Ltd
Prescient Therapeutics Ltd
Life Technologies Corp
Gilead Sciences Ltd
Genentech Inc
Cancure Ltd
Biogen Inc
Amgen Inc